David Jin
Director of Finance/CFO bei AVENUE THERAPEUTICS, INC.
Vermögen: 304 038 $ am 31.03.2024
Profil
David Jin is currently the CFO, CAO & Head of Corporate Development at Fortress Biotech, Inc. He is also the Secretary, Chief Operating & Financial Officer at Avenue Therapeutics, Inc. starting in 2022.
Previously, he worked as the Director-Corporate Development at Sorrento Therapeutics, Inc. and as the Vice President-Healthcare Investment Banking at FBR & Co. Mr. Jin completed his undergraduate degree at Northwestern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FORTRESS BIOTECH, INC.
0,83% | 01.04.2024 | 152 019 ( 0,83% ) | 304 038 $ | 31.03.2024 |
| 09.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von David Jin
| Unternehmen | Position | Beginn |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Director of Finance/CFO | 11.05.2022 |
| FORTRESS BIOTECH, INC. | Director of Finance/CFO | 16.08.2022 |
Ehemalige bekannte Positionen von David Jin
| Unternehmen | Position | Ende |
|---|---|---|
| FBR & CO | Corporate Officer/Principal | - |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von David Jin
| Northwestern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
FBR & Co.
 FBR & Co. Investment Banks/BrokersFinance FBR & Co. provides investment banking, merger and acquisition advisory, institutional brokerage and research services through its subsidiaries. The company operates through two segments: Capital Markets and Principal Investing. The Capital Markets segment includes investment banking, institutional brokerage and research. It also provides investment banking services, including capital raising and financial advisory services for its corporate issuer clients, and institutional brokerage services including sales, trading, research, and securities lending services to its institutional investor clients. The Principal Investing segment activities consist primarily of investments in merchant banking and other equity investments, investment funds and corporate debt investments. The company was founded in June 2006 and is headquartered in Arlington, VA. | Finance |
